Incidence of Second Primary Malignancies in Patients with Castration-Resistant Prostate Cancer: An Observational Retrospective Cohort Study in the United States

BACKGROUND: New therapies for castration-resistant prostate cancer (CRPC) may be associated with increased risk of second primary malignancies (SPM). We therefore estimated the population-based incidence of SPM among patients with CRPC in the Surveillance, Epidemiology, and End Results (SEER)-Medica...

Descripción completa

Detalles Bibliográficos
Autores principales: Saltus, Catherine W., Vassilev, Zdravko P., Zong, Jihong, Calingaert, Brian, Andrews, Elizabeth B., Soriano-Gabarró, Montse, Kaye, James A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6388338/
https://www.ncbi.nlm.nih.gov/pubmed/30886751
http://dx.doi.org/10.1155/2019/4387415

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6388338/
https://www.ncbi.nlm.nih.gov/pubmed/30886751
http://dx.doi.org/10.1155/2019/4387415

Ejemplares similares